DreaMed

DreaMed is a pioneering force in the hospitals and health care industry, dedicated to transforming diabetes management through innovative AI-driven solutions. Founded in 2014, DreaMed has established itself as a leader in developing decision-support tools that leverage data to provide expert-level treatment recommendations. DreaMed is committed to enhancing patient care and improving outcomes in the field of diabetes.

Located at its primary address at 14 Kaplan St, Institute for Endocrinology and Diabetes, Suite 20, POB 3271, Petah Tikva, Mercaz 4920235, IL, and with an additional location at 1650 W End Blvd, St. Louis Park, Minnesota 55416, US, DreaMed operates at the forefront of medical technology. DreaMed's FDA-cleared decision support system utilizes data from CGM/SMBG and insulin pumps to optimize diabetes management. The company places a strong emphasis on privacy, security, quality, and regulatory compliance, adhering to ISO 27001, GDPR, and HIPAA standards.

With a focus on artificial intelligence and remote care, DreaMed continues to innovate and expand its reach in the healthcare sector. DreaMed is dedicated to making a positive impact on the lives of individuals living with diabetes. We invite the manager of DreaMed to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.